Carney, Brittany

Carney, Brittany was paid $95K by Medicaid between Aug 2022 and Mar 2023, across 17 billing codes. Its largest line is 87637, Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV — 33% of everything it billed.

33Billing provider infoCARNEY, BRITTANY
BOSTON, MA 02118

33aNPI1902363666assigned 02/28/2019

33bProvider typeNurse Practitioner

28Total paid$95K

24GClaims1,920

24DCodes billed17

24AFirst – last monthAug 2022 – Mar 2023

Compared with peers

Next to other Nurse Practitioner providers in Massachusetts

Rank by total paid#22 of 172

Median peer was paid$8K

This provider vs. median12×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2022	1,157	$51K
2023	763	$43K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	33%	220	219	$31K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	28%	461	441	$27K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	9.7%	83	73	$9K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	6.6%	202	201	$6K
90460	Immunization administration through 18 years of age via any route, first or only component	5.5%	130	130	$5K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	4.9%	196	196	$5K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	4.4%	81	80	$4K
S0302	Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service)	2.1%	217	216	$2K
96110	Developmental screening, with scoring and documentation, per standardized instrument	1.7%	154	152	$2K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	1.1%	12	12	$994.32
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	41	40	$598.60
99173		<1%	27	27	$540.00

5 more codes

90461		<1%	14	$531.36
96127		<1%	45	$462.15
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	12	$173.40
81002		<1%	13	$39.91
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	12	$7.56

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.